SLC1A2 and Huntington disease: In the R6/2 Huntington’s disease transgenic mouse model, decreased content of GLT-1 and GLAST correlates with increased vulnerability to glutamate-induced toxicity (Estrada-Sánchez et al., 2009, 2010).